Iron overload and urinary lysosomal enzyme levels in β-thalassaemia major

European Journal of Pediatrics

Volumn 156, Issue 8, 1997, Pages 602-604

  Michelakakis, H ^a   Dimitriou, E ^a   Georgakis, H ^a   Karabatsos, F ^a   Fragodimitri, C ^a   Saraphidou, J ^a   Premetis, E ^a   Karagiorga Lagana, M ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Thalassaemia; Iron overload; Urinary mannosidase; Urinary N acetyl D glucosaminidase

Indexed keywords

ALPHA MANNOSIDASE; AMINOTRANSFERASE; CREATININE; DEFEROXAMINE; FERRITIN; HEMOGLOBIN; IRON; LYSOSOME ENZYME; N ACETYL BETA GLUCOSAMINIDASE;

ADOLESCENT; ADULT; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; IRON OVERLOAD; KIDNEY INJURY; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; THALASSEMIA MAJOR; TRANSFUSION; URINE; URINE LEVEL;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BETA-THALASSEMIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHELATION THERAPY; CHILD; CHILD, PRESCHOOL; FEMALE; FERRITINS; HEXOSAMINIDASES; HUMANS; IRON OVERLOAD; MALE; MANNOSIDASES;

EID: 0030753742     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050673     Document Type: Review

References (28)

1. Aerts JMFG, Donker-Koopman WE, Kolt M (1986) Comparison of the properties of a soluble form of glucocerebrosidase from human urine with those of the membrane associated tissue enzyme. Biochim Biophys Acta 863:63-70
2. Alfrey AC (1994) Role of iron and oxygen radicals in the progression of chronic renal failure. Am J Kidney Dis 23:183-187
3. Bacon B, Tavill A, Prittenham G, Park CH, Rechnagel R (1983) Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest 71:429-439
4. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farell DE and Harris JW (1994) Efficacy of Desferrioxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 331:567-573
5. Bonkovsky HL (1991) Iron and the liver. Am J Med Sci 301:32-43
6. Buhl L, Muirhead DE, Prentis PF (1993) Rental hemosiderosis due to thalassemia: a light and electron microscopy study with electron probe X-ray microanalysis. Ultrastruct Pathol 17:169-183
7. Choremis C, Zannos L, Basti B (1957) Aminoaciduria in Cooley and Sickle cell anaemia. J Clin Pathol 10:330-335
8. Duve C de, Wattiaux R, Bandhuin P (1962) Distribution of enzymes between subcellular fractions in aminal tissues. Adv Enzymol 24:291-358
9. Giardins PJ, Grady RW (1995) Chelation therapy in β-thalassemia: the benefits and limitations of desferrioxamine. Semin Hematol 32:304-312
10. Hamazaki S, Okada S, Ebina Y, Fujoka M, Midorikawa O (1986) Nephrotoxicity of ferric nitrilotriacetate. An electron microscopic and metabolic study. Am J Pathol 123:343-350
11. Holmes RP, Craddock G, Espeland MA, Assimos DG, Dean RH (1989) A lack of coordination in the release of urinary lysosomal and brush border enzymes following renovascular surger. Clin Chim Acta 186:1-10
12. Hultberg B, Ravnskov U (1981) The excretion of N-acetyl-β-D-glucosaminidase in glomerulonephritis. Clin Nephrol 15:33-38
13. Kunin CM, Chesney RW, Craig WA, England AC, De Angelis C (1978) Enzymuria as a marker of renal injury and disease: studios in the general population and in patients with renal disease. Pediatrics 62:751-760
14. Landing BH, Gonick HC, Nadorra RL, Hyman CB, Wells TR, Villareal-Engelhardt G, Mersch J, Agness CL (1989) Renal lesions and clinical findings in thalassemia major and other chronic anemias with hemosiderosis. Pediatr Pathol 9:475-500
15. Lapatsanis P, Sbyrakis S, Vrettos C, Karaklis A, Doxiadis S (1976) Phosphaturia in thalassemia. Pediatrics 58:885-892
16. Michelakakis H (1984) Studies on the factors involved in the secretion of enzymic and non-enzymic contents of rat liver lysosomes. Ph.D. Thesis London University
17. Nankivell BJ, Boadle RA, Harris DCH (1992) Iron accumulation in human chronic renal disease. Am J Kidney Dis 6:580-584
18. Navon R, Pahed B (1972) Urinary test of identification of Tay-Sach's genotypes. J Pediatr 80:1026-1029
19. Olivieri NF, Nathan DG, McMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR (1994) Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med 331:574-578
20. Paigen K, Peterson J (1978) Co-ordinancy of lysosomal enzyme excretion in human urine. J Clin Invest 61:751-762
21. Price RG (1983) Urinary enzymes, nephrotoxicity and renal disease. Toxicology 23:99-134
22. Price RG, Thorpe R, Tucker SM, Phillips NC (1977) Activity of N-acetyl-β-D-glucosaminidase, α-L-fucosidase and α-D-mannosidase in the urine of normal individuals and patients with renal disease. Biochem Soc Trans 5:248-250
23. Seymour SA, Peters JL (1978) Organelle pathology in primary and secondary Haemochromatosis with special reference to lysosomal changes. Br J Haematol 40:239-253
24. Solecki R, Zolinicki T von, Muller HM, et al (1983) Iron overload of spleen, liver and kidney as a consequence of he-molytic anemia. Exp Pathol 23:227-235
25. Tong Mak I, Weglicki EB (1985) Characterization of iron-mediated peroxidative injury in isolated hepatic lysosomes. J Clin Invest 75:58-63
26. Wellwood JM, Ellis BG, Price RG, Hammond K, Thompson AE, Jones NF (1975) Urinary N-acetyl-β-D-glucosaminidase activity in patients with renal disease. BMJ 3:408-411
27. Weinberg ED (1990) Cellular iron metabolism in health and disease. Drug Metab Rev 22:531-579
28. Zaino EC (1980) Pathophysiology of thalassemia. 4th Cooley's Anemia, Symposium. Ann NY Acad Sci 344:284-393